Stock listing
A0LF18 Stock Price, News, Filings & Events — Newron Pharmaceuticals S.p.a.
Selected listing: A0LF18 · LS · EUR · DE
This page tracks Newron Pharmaceuticals S.p.a.'s A0LF18:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0LF18:LS. A0LF18:LS is the stock-level entry point for investors researching Newron Pharmaceuticals S.p.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A0LF18:LS
- Asset type
- Stock
- Market cap
- $326.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Newron Pharmaceuticals S.p.a. A0LF18:LS stock context
This page tracks Newron Pharmaceuticals S.p.a.'s A0LF18:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A0LF18:LS. A0LF18:LS is the stock-level entry point for investors researching Newron Pharmaceuticals S.p.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Newron Pharmaceuticals S.p.a.
Newron Pharmaceuticals to Participate in June Investor Conferences
May 28, 2026
Newron Reports a Pause of Enrollment of New Study Participants in US Centers of ENIGMA-TRS 2 Study
April 29, 2026
Newron Announces AGM 2026 Results
April 23, 2026
Newron Presents 2025 Financial Results and Provides 2026 Outlook
March 24, 2026
Newron presents 2025 financial results and provides 2026 outlook
March 24, 2026
Newron Pharmaceuticals S.p.a. earnings calls
Research Newron Pharmaceuticals S.p.a.
Newron Pharmaceuticals S.p.a. investor report
Review AI stock analysis and investor report context for A0LF18:LS.
Newron Pharmaceuticals S.p.a. company profile
View the public company page for Newron Pharmaceuticals S.p.a. on 6ix.
Newron Pharmaceuticals S.p.a. news
Read company news and market updates connected to Newron Pharmaceuticals S.p.a..
Newron Pharmaceuticals S.p.a. investor events
Find investor webinars, events, and replay context for Newron Pharmaceuticals S.p.a..
Alternate listings
NWRN:SIX
CH · CHF
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NP5:XETR
DE · EUR
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NP5:GETTEX
DE · EUR
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
A0LF18:LSX
DE · EUR
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
0QOI:LSE
GB · CHF
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NP5:TRADEGATE
DE · EUR
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NWRN:BX
CH · CHF
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NWPHF:OTC
US · USD
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NP5:FWB
DE · EUR
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NWRNZ:AQUISUK
GB · CHF
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NP5:SWB
DE · EUR
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.
NP5:HAM
DE · EUR
Alternate listing for Newron Pharmaceuticals S.p.a.; the primary context on this page is A0LF18:LS.